Optimizing diagnosis in Parkinson's disease: Radionuclide imaging

Area of Science:

• Neuroscience
• Radiology
• Biochemistry

Background:

• Parkinson's disease (PD) and basal ganglia disorders often lack distinct structural imaging markers.
• Functional imaging is crucial for assessing neurodegenerative processes.

Purpose of the Study:

• To review the application of radionuclide imaging in Parkinson's disease.
• To highlight how imaging assesses dopaminergic and other neurotransmitter systems.
• To discuss the role of imaging in understanding PD pathophysiology and guiding therapeutics.

Main Methods:

• Imaging of presynaptic dopaminergic markers: L-aromatic amino acid decarboxylase (AADC) activity, Vesicular Monoamine Transporter type 2 (VMAT2) binding, and dopamine transporter (DAT) reuptake.
• Assessment of postsynaptic dopamine D2-like receptor availability.
• Imaging of other neurotransmitter systems (norepinephrine, serotonin, acetylcholine).
• Metabolic and pathological imaging techniques.

Main Results:

• Radionuclide imaging effectively visualizes presynaptic dopaminergic dysfunction in PD.
• Postsynaptic dopamine receptor imaging provides insights into receptor availability.
• Imaging of other neurotransmitters and metabolic activity aids in understanding PD complications.
• These techniques help differentiate PD from other parkinsonian syndromes.

Conclusions:

• Radionuclide imaging offers valuable insights into the functional neurochemistry of Parkinson's disease.
• These imaging modalities are instrumental in understanding PD pathophysiology and its complications.
• Advanced imaging techniques are essential for developing new therapeutic strategies for PD.